510(k) Report

FDA applicant

Epocal, Inc.

Ottawa, CA7 decisions2006–202024 recalls

FDA records 7 decisions for Epocal, Inc. (Ottawa, CA) from 2006 to 2020: 7 510(k) clearances. Most are in product codes CGL (Electrode, Ion Based, Enzymatic, Creatinine) and CEM (Electrode, Ion Specific, Potassium). Its devices cite 12 predicates, 5 of them its own earlier devices. 24 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Epocal, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2020

2009: 12010: 22012: 12018: 12020: 1
2007high 2 (2010) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2026

2008: 12010: 12011: 12013: 12020: 12022: 22023: 42024: 92025: 32026 (partial year): 1
2007high 9 (2024) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Epocal, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Epocal, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report